Alemu, Ashalew and Mushira, Joel Munene and Wanjeh, David Mwanza and Janevik-Ivanovska, Emilija (2015) Radiopharmacy in Africa: perspective of Ethiopia and Kenya. In: 11th Asia Oceania Congress of Nuclear Medicine and Biology; 54th Annual Autumn Meeting of the Korean Society of Nuclear Medicine; 14th Annual General Meeting of Asian Regional Cooperative Council for Nuclear Medicine, 31 Oct - 04 Nov 2015, Jeju, South Korea.
Preview |
Text
A.Alemu - AOJNMB.pdf Download (185kB) | Preview |
Preview |
Image
AOJNMB - Vol. 3 supplement 1 2015 front page.pdf Download (68kB) | Preview |
Preview |
Text
AOJNMB - Vol. 3 supplement 1 2015.pdf Download (4MB) | Preview |
Preview |
Text
RADIOPHARMACY IN AFRICA PERSPECTIVEOF ETHIOPIA AND KENYA.pdf Download (530kB) | Preview |
Abstract
Objectives: The article seeks to describe the current
status of Radiopharmacy practice in Eastern Africa
using the perspective of Kenya and Ethiopia.
Methods: Non-communicable diseases (NCDs) are a
challenge of epidemic proportion and that they will be
the commonest cause of mortality in Africa by 2030. Since
early detection and treatment is known to significantly
improve patient outcomes, radiopharmaceuticals have become of invaluable benefit because they offer the most sensitive tools in the detection, diagnosis and targeted therapy of NCDs and also infectious diseases.
In light of the foregoing, therefore, radiopharmacy has
a huge role to play in responding to the unfolding new
disease trends in sub-Saharan Africa.
Results: The preparation of radiopharmaceuticals for human use requires that it is carried out in welldefined and controlled conditions to avoid the risk contamination with microbes, pyrogens and particulate matter as well as cross contamination with other radiopharmaceuticals.
Accordingly, principles of Good Manufacturing Practices
and Good Laboratory Practices should strictly be observed in the production, preparation, testing and the packaging of the final product ready for use. Most radiopharmaceuticals are parenterally administered
and must therefore be prepared in such condition, and
using such techniques and procedure, that guarantee
sterility of the product. Every procedure undertaken
should be done according to the clearly defined
protocol and under the right conditions so as to build
quality into the product. Radiopharmacy professionals
should have adequate training in all aspects of sterile
production, quality control, GMP , GLP, radiation safety
and radiochemistry to ensure that they are competent
to handle radioactive materials and that they can take
responsibility for their level of practice
Conclusions: The exact information on the number
and status of radiopharmacy units, regionally, is still
not clearly documented. Important information for the
Eastern Africa region that also needs to be documented
includes issues of human resource and local demand for
the radiopharmacy services. It is the existence of this
gap that necessitated the preparation of this article.
| Item Type: | Conference or Workshop Item (Poster) |
|---|---|
| Subjects: | Medical and Health Sciences > Other medical sciences |
| Divisions: | Faculty of Medical Science |
| Depositing User: | Emilija Janevik |
| Date Deposited: | 11 Feb 2016 10:19 |
| Last Modified: | 11 Feb 2016 10:19 |
| URI: | https://eprints.ugd.edu.mk/id/eprint/15375 |
Actions (login required)
 |
View Item |